Polymer nanocomposite implants with enhanced transparency and mechanical properties for administration within humans or animals
First Claim
1. A nanocomposite for administration in a human or animal comprising:
- an acrylate matrix;
nanofillers comprising one or more elements selected from the group;
barium, bismuth, cerium, dysprosium, europium, gadolinium, hafnium, indium, lanthanum, neodymium, niobium, praseodymium, strontium, tantalum, tin, tungsten, ytterbium, yttrium, zinc, and zirconium;
wherein the nanofillers have a domain size less than 100 nanometers;
wherein the nanofillers are mixed into the acrylate matrix at a loading of less than 80 volume percent to form a nanocomposite; and
wherein the composite exhibits a transparency to light that differs by more than 20% as compared with the transparency to light exhibited by a composite of similar composition with fillers having a domain size of at least one micron.
4 Assignments
0 Petitions
Accused Products
Abstract
Polymer nanocomposite implants with nanofillers and additives are described. The nanofillers described can be any composition with the preferred composition being those composing barium, bismuth, cerium, dysprosium, europium, gadolinium, hafnium, indium, lanthanum, neodymium, niobium, praseodymium, strontium, tantalum, tin, tungsten, ytterbium, yttrium, zinc, and zirconium. The additives can be of any composition with the preferred form being inorganic nanopowders comprising aluminum, calcium, gallium, iron, lithium, magnesium, silicon, sodium, strontium, titanium. Such nanocomposites are particularly useful as materials for biological use in applications such as drug delivery, biomed devices, bone or dental implants.
139 Citations
16 Claims
-
1. A nanocomposite for administration in a human or animal comprising:
-
an acrylate matrix;
nanofillers comprising one or more elements selected from the group;
barium, bismuth, cerium, dysprosium, europium, gadolinium, hafnium, indium, lanthanum, neodymium, niobium, praseodymium, strontium, tantalum, tin, tungsten, ytterbium, yttrium, zinc, and zirconium;
wherein the nanofillers have a domain size less than 100 nanometers;
wherein the nanofillers are mixed into the acrylate matrix at a loading of less than 80 volume percent to form a nanocomposite; and
wherein the composite exhibits a transparency to light that differs by more than 20% as compared with the transparency to light exhibited by a composite of similar composition with fillers having a domain size of at least one micron. - View Dependent Claims (2, 3, 4, 5, 6, 7, 12, 14)
-
-
8. A nanocomposite for administration in a human or animal comprising:
-
a polymer matrix;
nanofillers comprising one or more elements selected from the group;
barium, bismuth, cerium, dysprosium, europium, gadolinium, hafnium, indium, lanthanum, neodymium, niobium, praseodymium, strontium, tantalum, tin, tungsten, ytterbium, yttrium, zinc, and zirconium;
a secondary species comprising metal oxide nanopowder additives;
wherein the nanopowder additives comprise at least one element selected from the group consisting of;
aluminum, calcium, gallium, iron, lithium, magnesium, silicon, sodium, strontium, titanium, carbon, oxygen and boron;
wherein the nanofillers have a domain size less than 100 nanometers; and
wherein the nanofillers are mixed into the polymer matrix at a loading of less than 95 volume percent to form a nanocomposite. - View Dependent Claims (9, 10, 11, 13, 15)
-
-
16. A nanocomposite for administration in a human or animal comprising:
-
a polymer matrix;
oxide nanofillers comprising two or more elements selected from the group;
barium, strontium, yttrium, tantalum, tin, titanium, silver, aluminum, silicon, zinc and zirconium;
wherein the nanofillers have a domain size less than 100 nanometers; and
wherein the nanofillers are mixed into the polymer matrix at a loading of less than 95 volume percent to form a nanocomposite.
-
Specification